#TranslationalBytes
LightNews LightNews
ascptclinpharm.bsky.social
#CTSjournal author Pamela Davis discusses Electronic Health Record Big Data in the latest post from #TranslationalBytes: bit.ly/4a9MZg0
January 13, 2025 at 7:26 PM
ascptclinpharm.bsky.social
Author Ryo Nakamura provides more insight on his #CTSjournal study in the latest blog post from #TranslationalBytes: bit.ly/3VOjMB8
January 8, 2025 at 5:28 PM
ascptclinpharm.bsky.social
The 2025 #CTSjournal award highlights the most outstanding CTS paper written by a student or trainee - learn more about this year's recipient in the latest #TranslationalBytes blog post: bit.ly/432VcAq
October 30, 2025 at 2:48 PM
ascptclinpharm.bsky.social
In the rapidly evolving field of single-cancer detection and multi-cancer detection testing technology, ensuring that all stakeholders use consistent language becomes critical to overcoming communication challenges. Find out more in the latest #TranslationalBytes @bloodpac.bsky.social
Check out this blog post from "Translational Bytes" by Clinical and Translational Science Common Language for Cancer Detection Technology! Dorys Lopez, PhD, Christina A. Clarke, PhD, MPH, and Breeana L. Mitchell, PhD https://bit.ly/3RcNMEe
March 20, 2025 at 10:57 AM
ascptclinpharm.bsky.social
What is a digital twin? Learn more about this powerful concept for personalized medicine in the latest #TranslationalBytes post from #CTSjournal: bit.ly/41sYTz2
Translational Bytes Post Preview: What if you Could Experiment on Your Electronic Self by Iraj Hosseini, PhD
February 27, 2025 at 4:57 PM
ascptclinpharm.bsky.social
📑 #CTSjournal RESEARCH SPOTLIGHT: "Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements", check the full research article referenced in the latest #TranslationalBytes.
bit.ly/4d83sCI
CTS Journal Preview Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements Includes a figure from the article.
May 15, 2025 at 8:47 PM
ascptclinpharm.bsky.social
Check out the latest #TranslationalBytes: #CTSjournal author Jacqueline Gerhart's gives an inside look at her recently published study involving pregnant and lactating women: https://bit.ly/4avloaw
July 6, 2026 at 3:30 PM
ascptclinpharm.bsky.social
IDERHA is a European research partnership aiming to develop a federated data platform enabling researchers to access and analyze health data across Europe- learn more about what this group is with real-world data and evidence in the latest #TranslationalBytes: https://bit.ly/4a7ePdR
June 2, 2026 at 12:30 PM
ascptclinpharm.bsky.social
In the latest #TranslationalBytes, #CTSjournal authors Linda Jeng and Jeffrey Siegel illuminate a critical pathway for bringing treatments to patients faster: the use of surrogate endpoints in drug approval decisions. Find out more: https://bit.ly/4tCg8Zs
May 19, 2026 at 3:30 PM
ascptclinpharm.bsky.social
#CTSjournal authors Wenjie Wang and Da Xu discuss one of the pivotal findings of their recent study in the latest #TranslationalBytes post: bit.ly/4sSclqX
March 25, 2026 at 11:48 AM
ascptclinpharm.bsky.social
#CTSjournal Editor-in-Chief John Wagner gives a year end review for 2025 in the latest #TranslationalBytes: bit.ly/3OmO2SQ
February 13, 2026 at 2:40 PM
ascptclinpharm.bsky.social
Are you involved in drug development for therapeutic peptides—whether in DMPK, clinical pharmacology, or other related disciplines? In the latest #TranslationalBytes learn about a recent industry position paper to guide colleagues in this area. bit.ly/4ramChZ
Guiding Drug Developers in Therapeutic Peptide Projects: Insights to Drug-Drug Interaction Risks from Recent Approvals
Are you involved in drug development for therapeutic peptides—whether in DMPK, clinical pharmacology, or other related disciplines? Are you unsure of how the development program differs from your stan
bit.ly
November 24, 2025 at 5:12 PM
ascptclinpharm.bsky.social
#CTSjournal authors Kim A. Henderson, Nicholas Ether, and Hugo M. Vargas discuss risks in nonclinical toxicology studies in the most recent #TranslationalBytes post: bit.ly/3IpbVXx
Are We Missing the Risk? Rethinking Restraint-Based Cardiovascular Monitoring in Nonclinical Toxicology Studies
Identifying cardiovascular (CV) risks early in drug development is essential, especially for detecting arrhythmias and hemodynamic changes. Despite this, many nonclinical toxicology studies still rely
bit.ly
September 30, 2025 at 1:02 PM
ascptclinpharm.bsky.social
#CTSjournal author, James Lu discusses the role LLMs can have in the future of clinical pharmacology and translational science in the latest #TranslationalBytes: bit.ly/3IawfvA
“Large” Time for a Primer: Larger Impacts with Large Language Models
Large language models (LLMs), like ChatGPT, are no longer just tech-world curiosities; they’re increasingly making their way into drug discovery and clinical development. In this new Clinical and Tran
bit.ly
September 17, 2025 at 9:23 PM
ascptclinpharm.bsky.social
Check out the latest post from #TranslationalBytes! #CTSjournal author Yoonjin Kim discusses data integrity and personal health records in decentralized trials! bit.ly/4fFJHEa
This graphic previews the title of the "Translational Byes" post: "Enhancing Eligibility Assessment with Personal Health Records in a Fully Remote Trial" by Yoonjin Kim, MD The text is accompanied by a figure from the blog post ad the cover image of CTS
August 21, 2025 at 5:43 PM
ascptclinpharm.bsky.social
#CTSAuthor Lyn Frumkin explains her recent tutorial discussing resource-limited investigator-sponsored studies in the latest #TranslationalBytes Post. #TranslationalTuesday bit.ly/447cYlM
This image provides a preview of four of the pieces published in the May 2025 issue of Clinical and Translational Science (Volume 18, Issue 5). This preview shows the titles of two tutorials and two brief reviews.
June 24, 2025 at 10:44 AM
ascptclinpharm.bsky.social
2024 was a great year fro #CTSjournal - read the year in review from Editor in Chief John Wagner in the latest #TranslationalBytes post. bit.ly/40rZzCR
CTS: Ringing in 2025, and Looking Back on a Strong 2024 -Translational Bytes Post
January 29, 2025 at 1:44 PM